Novel management of insulin autoimmune syndrome with methylprednisolone and flash glucose monitoring

Ann Endocrinol (Paris). 2023 Feb;84(1):83-85. doi: 10.1016/j.ando.2022.10.001. Epub 2022 Oct 15.

Authors

Sílvia Santos Monteiro¹, Tiago Silva Santos², Jorge Dores²

Affiliations

¹ Division of Endocrinology, Diabetes and Metabolism. Centro Hospitalar Universitário do Porto, Largo Professor Abel Salazar 4099-001 Porto, Portugal. Electronic address: silviamsmonteiro@hotmail.com.
² Division of Endocrinology, Diabetes and Metabolism. Centro Hospitalar Universitário do Porto, Largo Professor Abel Salazar 4099-001 Porto, Portugal.

PMID: 36252848
DOI: 10.1016/j.ando.2022.10.001

No abstract available

Keywords: Hirata's disease; Insulin autoantibodies; Insulin autoimmune syndrome; Insulin to C-peptide ratio.

Publication types

Letter

MeSH terms

Autoantibodies
Autoimmune Diseases* / drug therapy
Blood Glucose
Blood Glucose Self-Monitoring
Humans
Hyperinsulinism*
Insulin / therapeutic use
Insulin Antibodies
Methylprednisolone / therapeutic use

Substances

Blood Glucose
Methylprednisolone
Insulin
Insulin Antibodies
Autoantibodies